TGM2 and rheumatoid arthritis: In contrast, silencing TG2 expression by using TG2-shRNA or inhibition of TGase activity with cystamine in synovial cells from RA patients resulted in marked decreases in invadopodia formation, reaching levels similar to those found in control FLS (Figure 4G).